Retrieve available abstracts of 195 articles: HTML format
Single Articles
March 2025
WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum
and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038. PubMedAbstract available
THE LANCET H5N1 avian influenza: technical solutions, political challenges.
Lancet. 2025;405:671. PubMed
January 2025
MUMFORD L, Hogg R, Taylor A, Lanyon P, et al Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation
rates in immunosuppressed populations during the omicron period: the MELODY
study.
Lancet. 2025;405:314-328. PubMedAbstract available
December 2024
DZAU VJ, Laitner MH, Shambaugh EL Strategic imperatives for health in the USA: a roadmap for the incoming
presidential administration.
Lancet. 2024;404:2371-2379. PubMedAbstract available
The burden of diseases, injuries, and risk factors by state in the USA,
1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024;404:2314-2340. PubMedAbstract available
October 2024
PAYNE AB, Watts JA, Mitchell PK, Dascomb K, et al Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated
hospitalisations and emergency department encounters among adults aged 60 years
and older in the USA, October, 2023, to March, 2024: a test-negative design
analysis.
Lancet. 2024;404:1547-1559. PubMedAbstract available
BRANDA F, Oh J, Acharya KP, Yon DK, et al Human vaccination for highly pathogenic avian influenza.
Lancet. 2024;404:1518-1519. PubMed
September 2024
ROMANELLO M, Costello A The Lancet Countdown on health and climate change: competing interests and
optimism bias - Authors' reply.
Lancet. 2024;404:1197-1198. PubMed
BRINK N, Chersich MF The Lancet Countdown on health and climate change: competing interests and
optimism bias.
Lancet. 2024;404:1196. PubMed
BUTLER CD, Combs Bowles D, Hanigan IC, Harmer A, et al The Lancet Countdown on health and climate change: competing interests and
optimism bias.
Lancet. 2024;404:1196-1197. PubMed
ROMANELLO M, Beggs PJ, Cai W, Gordon-Strachan G, et al The Lancet Countdown on health and climate change: representation matters -
Authors' reply.
Lancet. 2024;404:1195-1196. PubMed
STREET R, Wright CY The Lancet Countdown on health and climate change: representation matters.
Lancet. 2024;404:1194. PubMed
HORTON R Offline: Xenotransplantation-a new era beckons.
Lancet. 2024;404:1181. PubMed
ELNAKIB S, Aly S, Asi YM, Shawar YR, et al The humanitarian system: politics can not be avoided.
Lancet. 2024;404:1105-1106. PubMed
ST LOUIS P, Makali SL, Paul E Health-care workers in fragile and conflict-ridden contexts.
Lancet. 2024;404:1105. PubMed
RAUSEI S, Bertolini AG Cuban doctors cannot be the definitive solution for Italy.
Lancet. 2024;404:1103. PubMed
YANG X, Zhang Z, Zhang Z Building safe health-care environments in China: urgent challenges.
Lancet. 2024;404:1101-1102. PubMed
HWANG TJ, Trinh QD, Sokolov E Safe and equitable use of clinical decision support systems.
Lancet. 2024;404:1100-1101. PubMed
HORTON R Offline: From Wanless to Darzi-don't miss this opportunity (again).
Lancet. 2024;404:1088. PubMed
MAZUR NI, Caballero MT, Nunes MC Severe respiratory syncytial virus infection in children: burden, management, and
emerging therapies.
Lancet. 2024;404:1143-1156. PubMedAbstract available
NACHEGA JB, Muyembe-Tamfum JJ, Ntoumi F, Mbala-Kingebeni P, et al A call for global solidarity and rapid action to control mpox.
Lancet. 2024;404:1099-1100. PubMed
IMANI-MUSIMWA P, Ververs M Mpox and breastmilk: for once, can we act in time?
Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881. PubMed
PECENKA C, Sparrow E, Feikin DR, Srikantiah P, et al Respiratory syncytial virus vaccination and immunoprophylaxis: realising the
potential for protection of young children.
Lancet. 2024 Sep 6:S0140-6736(24)01699-4. doi: 10.1016/S0140-6736(24)01699. PubMedAbstract available
August 2024
MACNAUGHTON J, Zeiler K Reimagining illness through post-COVID-19 condition: the need for radically
interdisciplinary health research.
Lancet. 2024;404:840-841. PubMed
ZAROCOSTAS J Many challenges for WHO-AFRO regional director candidates.
Lancet. 2024;404:736-737. PubMed
ZHAO Y, Gao Y, Guyatt G, Uyeki TM, et al Antivirals for post-exposure prophylaxis of influenza: a systematic review and
network meta-analysis.
Lancet. 2024;404:764-772. PubMedAbstract available
GAO Y, Guyatt G, Uyeki TM, Liu M, et al Antivirals for treatment of severe influenza: a systematic review and network
meta-analysis of randomised controlled trials.
Lancet. 2024;404:753-763. PubMedAbstract available
HUI DSC Antiviral treatment and prophylaxis for influenza.
Lancet. 2024;404:726-727. PubMed
BRANDA F, Ceccarelli G, Ciccozzi M, Scarpa F, et al Strengthening community resilience: lessons from COVID-19 for mpox prevention.
Lancet. 2024 Aug 22:S0140-6736(24)01752-5. doi: 10.1016/S0140-6736(24)01752. PubMed
SAMARASEKERA U Understanding pandemic risks: the WHO Pandemic Hub.
Lancet. 2024;404:420-421. PubMed
SHAH SA, Robertson C, Sheikh A Waiting list models must account for departures before treatment - Authors'
reply.
Lancet. 2024;404:432-433. PubMed
WOOD RM Waiting list models must account for departures before treatment.
Lancet. 2024;404:431-432. PubMed
O'NEILL D Continuing challenges to health equity in Ireland.
Lancet. 2024;404:431. PubMed
BANATVALA JE, Muir P, Irving W, Meader E, et al The role of the clinical virologist in pandemic responses.
Lancet. 2024;404:430. PubMed
GARAY J, Kateeb E, Zeballos D, Souza LE, et al Inequity in sustainable health today.
Lancet. 2024;404:429-430. PubMed
GREEN A Evelyn Fox Keller.
Lancet. 2024;404:426. PubMed
July 2024
GREENHALGH T, Sivan M, Perlowski A, Nikolich JZ, et al Long COVID: a clinical update.
Lancet. 2024 Jul 31:S0140-6736(24)01136-X. doi: 10.1016/S0140-6736(24)01136. PubMedAbstract available
June 2024
SAMARASEKERA U No parties meeting the challenge on health in the UK.
Lancet. 2024;403:2769-2770. PubMed
DIEDRICH L Illness politics and social media mobilisation.
Lancet. 2024;403:2776-2777. PubMed
THE LANCET UK elections: the need for a healthy change.
Lancet. 2024;403:2755. PubMed
GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al Why Latin America needs a regional Centre for Disease Control and Prevention.
Lancet. 2024;403:2763-2765. PubMed
SCHRECKER T Canada's reckoning?
Lancet. 2024;403:2688. PubMed
ZAROCOSTAS J Mental health in emergencies requires "a major rethink".
Lancet. 2024;403:2582. PubMed
AHSAN S Israel border closure denying health care to Gazans.
Lancet. 2024;403:2581. PubMed
SAMARASEKERA U African vaccine manufacturing scheme to boost production.
Lancet. 2024;403:2579-2580. PubMed
KUNKLER I Improving future UK pandemic management structure.
Lancet. 2024;403:2592. PubMed
YOON JH, Kwon IH, Park HW The South Korean health-care system in crisis.
Lancet. 2024;403:2589. PubMed
THE LANCET Taking persistent physical symptoms seriously.
Lancet. 2024;403:2565. PubMed
MCCALL C Security concerns threaten Papua New Guinea relief efforts.
Lancet. 2024;403:2471. PubMed
KOMAMURA K, Iwase M Clinical outcomes of the AdaptResponse trial.
Lancet. 2024;403:2484. PubMed
FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al Clinical outcomes of the AdaptResponse trial - Authors' reply.
Lancet. 2024;403:2484-2485. PubMed
HORTON R Offline: The system is not working.
Lancet. 2024;403:2470. PubMed
THE LANCET H5N1: international failures and uncomfortable truths.
Lancet. 2024;403:2455. PubMed
MOHAPATRA PR Responding to India's data and transparency.
Lancet. 2024;403:2482-2483. PubMed
ANIRVAN P Blowing in the wind-India's health data and transparency issues.
Lancet. 2024;403:2483-2484. PubMed
SAMARASEKERA U Calls for a focus on health risks in EU election.
Lancet. 2024;403:2364. PubMed
TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al DEI infrastructures required for the best science and medicine.
Lancet. 2024;403:2375. PubMed
HORTON R Offline: UK election-two issues you won't hear about.
Lancet. 2024;403:2362. PubMed
May 2024
PATERLINI M Warnings over Italian health-care devolution.
Lancet. 2024;403:2279. PubMed
THORNTON J Infected blood report release marks a day of shame for the UK.
Lancet. 2024;403:2276-2277. PubMed
BROWN M, Gerrard J, McDougall C, MacPhail J, et al Purpura fulminans in young women with influenza and co-infections.
Lancet. 2024;403:2290-2291. PubMed
THE LANCET Cyberattacks on health care-a growing threat.
Lancet. 2024;403:2263. PubMed
LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al Expanding antibiotic, vaccine, and diagnostics development and access to tackle
antimicrobial resistance.
Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878. PubMedAbstract available
SAMARASEKERA U 50 years of the Expanded Programme on Immunization.
Lancet. 2024;403:1971-1972. PubMed
MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al One Health pandemic preparedness: the role of companion animals in disease
transmission.
Lancet. 2024;403:1984-1985. PubMed
ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al Cofinancing immunisation through national health insurance.
Lancet. 2024;403:1983-1984. PubMed
HORTON R Offline: Indifference-the biggest threat to global health.
Lancet. 2024;403:1970. PubMed
KANTER R, Fort MP Rethinking health policy: life expectancy and mortality in an era of polycrisis.
Lancet. 2024;403:1956-1958. PubMed
WATTS G Alasdair Macintosh Geddes.
Lancet. 2024;403:1846. PubMed
AUJLA M Art, plunder, fragile fault lines.
Lancet. 2024;403:1844-1845. PubMed
USHER AD Organisations vie for control over pandemic financing.
Lancet. 2024;403:1839-1840. PubMed
GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al Airborne pathogens: controlling words won't control transmission.
Lancet. 2024;403:1850-1851. PubMed
YANG YT Protecting humanitarian aid workers: an urgent call.
Lancet. 2024;403:1847. PubMed
ABUZERR S, Zinser K Amplifying the voices of women in the Gaza Strip.
Lancet. 2024;403:1848-1849. PubMed
KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al Building global preparedness for avian influenza.
Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934. PubMed
KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al The long COVID evidence gap in England.
Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744. PubMed
KIVIMAKI M, Batty GD Work as a health risk.
Lancet. 2024;403:1747-1748. PubMed
April 2024
GREEN A Tobias Welte.
Lancet. 2024;403:1626. PubMed
MARCHALIK D, Rehm D On not cutting corners.
Lancet. 2024;403:1623. PubMed
DEVI S Swedish NGOs are reeling after government cuts.
Lancet. 2024;403:1527. PubMed
Global incidence, prevalence, years lived with disability (YLDs),
disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for
371 diseases and injuries in 204 countries and territories and 811 subnational
locations, 1990-2021: a sys
Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757. PubMedAbstract available
ZUMLA A, Peiris M, Memish ZA, Perlman S, et al Anticipating a MERS-like coronavirus as a potential pandemic threat.
Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641. PubMed
PETO L, Basnyat B, Horby P High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors'
reply.
Lancet. 2024;403:1339-1340. PubMed
BHUSAL S, Adhikari S High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1339. PubMed
NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1338-1339. PubMed
HSU NC, Tokuda Y High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1338. PubMed
MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1337. PubMed
HASHIM Z, Nath A, Tripathy NK High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1337-1338. PubMed
SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
Lancet. 2024;403:1336. PubMed
GU X, Huang L, Zhang H, Cao B, et al Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan -
Authors' reply.
Lancet. 2024;403:1336-1337. PubMed
Global burden of 288 causes of death and life expectancy decomposition in 204
countries and territories and 811 subnational locations, 1990-2021: a systematic
analysis for the Global Burden of Disease Study 2021.
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367. PubMedAbstract available
March 2024
SZANYI J, Howe S, Blakely T The importance of reporting accurate estimates of long COVID prevalence.
Lancet. 2024;403:1136-1137. PubMed
WENHAM C, Stout L A legal mapping of 48 WHO member states' inclusion of public health emergency of
international concern, pandemic, and health emergency terminology within national
emergency legislation in responding to health emergencies.
Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156. PubMedAbstract available
SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster
campaign.
Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316. PubMed
Global age-sex-specific mortality, life expectancy, and population estimates in
204 countries and territories and 811 subnational locations, 1950-2021, and the
impact of the COVID-19 pandemic: a comprehensive demographic analysis for the
Global Burden
Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476. PubMedAbstract available
PARHIZ H, Atochina-Vasserman EN, Weissman D mRNA-based therapeutics: looking beyond COVID-19 vaccines.
Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444. PubMedAbstract available
February 2024
ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al The INSPIRE study: RSV infection during infancy - Authors' reply.
Lancet. 2024;403:729-730. PubMed
HSU NC, Hsu CH The INSPIRE study: RSV infection during infancy.
Lancet. 2024;403:729. PubMed
TAO L, Liu J The INSPIRE study: RSV infection during infancy.
Lancet. 2024;403:728-729. PubMed
DHAIRYAWAN R Candour, care, and COVID-19.
Lancet. 2024;403:718. PubMed
VORA NM, Hassan L, Plowright RK, Horton R, et al The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk
of pandemics through primary prevention.
Lancet. 2024;403:597-599. PubMed
WANG X, Li Y, Shi T, Bont LJ, et al Global disease burden of and risk factors for acute lower respiratory infections
caused by respiratory syncytial virus in preterm infants and young children in
2019: a systematic review and meta-analysis of aggregated and individual
participant data.
Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138. PubMedAbstract available
ADERINTO N, Olatunji G, Kokori E Health implications of GSK's departure from Nigeria.
Lancet. 2024;403:526-527. PubMed
January 2024
MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic:
planning, outcomes, and lessons learnt.
Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635. PubMedAbstract available
WANG L, Wang Q, Gao GF Interpreting COVID-19 data from China: a call for caution - Authors' reply.
Lancet. 2024;403:144-145. PubMed
QU Z Interpreting COVID-19 data from China: a call for caution.
Lancet. 2024;403:144. PubMed
GULLIFORD MC, Steves CJ Access to COVID-19 vaccination and COVID-19-related hospital admissions and
mortality.
Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622. PubMed
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort
studies in England, Northern Ireland, Scotland, and Wales.
Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467. PubMedAbstract available
SHAH SA, Robertson C, Sheikh A Effects of the COVID-19 pandemic on NHS England waiting times for elective
hospital care: a modelling study.
Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744. PubMed
December 2023
CHARLIER P Death and end of life in France after COVID-19.
Lancet. 2023;402:2290. PubMed
HORTON R Offline: Boris Johnson and COVID-19-more light than heat.
Lancet. 2023;402:2277. PubMed
November 2023
GRABAR-KITAROVIC K, Phumaphi J A crisis of trust in pandemic prevention, preparedness, and response.
Lancet. 2023;402:1730-1732. PubMed
ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al Impact of long COVID-19 on work: a co-produced survey.
Lancet. 2023;402 Suppl 1:S98. PubMedAbstract available
VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration
between public health teams in local authorities, NHS hospital trusts, NHS
commissioners, and universities.
Lancet. 2023;402 Suppl 1:S94. PubMedAbstract available
Nowcasting waiting lists for elective procedures and surgery in England: a
modelling study.
Lancet. 2023;402 Suppl 1:S74. PubMedAbstract available
MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB Differences in the impact of the COVID-19 pandemic in the long-term trajectories
of life satisfaction by sex in the UK: a prospective cohort study.
Lancet. 2023;402 Suppl 1:S71. PubMedAbstract available
MARTIN A, Jamieson S Exploring the experiences of junior doctors who were shielding during the
COVID-19 pandemic: a qualitative study of semi-structured interviews.
Lancet. 2023;402 Suppl 1:S68. PubMedAbstract available
KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al Effect of trade unions on the mental health of UK workers before and during the
COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
Lancet. 2023;402 Suppl 1:S62. PubMedAbstract available
KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in
Europe: a systematic review.
Lancet. 2023;402 Suppl 1:S61. PubMedAbstract available
KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al Changes in food and drink purchasing behaviour in England during the first 3
months of the COVID-19 pandemic: an interrupted time-series analysis.
Lancet. 2023;402 Suppl 1:S60. PubMedAbstract available
HAZIR SG, Ryan C, Moore A, Lewis C, et al The role of the multiple Index of deprivation in predicting mental health
outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
Lancet. 2023;402 Suppl 1:S47. PubMedAbstract available
DU Z, Wang L, Bai Y, Pei Y, et al Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the
COVID-19 pandemic in the UK: a modelling study.
Lancet. 2023;402 Suppl 1:S39. PubMedAbstract available
ARNOTT J, Troya MI, Joyce M, Khashan A, et al Untangling the association between COVID-19 health literacy, trust in the
pandemic response, and mental distress, during the COVID-19 pandemic in Ireland:
a repeated cross-sectional study.
Lancet. 2023;402 Suppl 1:S23. PubMedAbstract available
October 2023
WANG Q, Bowen A, Ho J, Zhang RM, et al SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278. PubMed
DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al Scientific advisory councils in the COVID-19 response.
Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846. PubMed
September 2023
MATUCHANSKY C Natural SARS-CoV-2 infection-induced immune protection against re-infection.
Lancet. 2023;402:1131. PubMed
FLACCO ME, Martellucci CA, Manzoli L Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
Lancet. 2023;402:1129. PubMed
TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al Striving to afford free health care in Greece during COVID-19.
Lancet. 2023;402:1128-1129. PubMed
JASSAT W, Reyes LF, Munblit D, Caoili J, et al Long COVID in low-income and middle-income countries: the hidden public health
crisis.
Lancet. 2023;402:1115-1117. PubMed
HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors'
reply.
Lancet. 2023;402:1132. PubMed
QU Z Cautionary notes on the COVID-19 re-infection study.
Lancet. 2023;402:1130-1131. PubMed
ZHOU YB, Xu ZG COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
Lancet. 2023;402:1131-1132. PubMed
PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al Community COVID-19 response in WHO's European region.
Lancet. 2023;402:1127. PubMed
MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges
- Authors' reply.
Lancet. 2023;402:1041-1042. PubMed
PARENTE RCM, Queiroga M Bolsonaro's Ministry of Health's response to COVID-19 and other health
challenges.
Lancet. 2023;402:1040-1041. PubMed
ZHANG H COVID-19 and Chinese nurses' mental health.
Lancet. 2023;402:1039-1040. PubMed
August 2023
DAI L, Duan H, Liu X, Zhou H, et al Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough
infection.
Lancet. 2023;402:687-689. PubMed
KUNG S, Hills T, Kearns N, Beasley R, et al New Zealand's COVID-19 elimination strategy and mortality patterns.
Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368. PubMed
IFTEKHAR N, Sivan M Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
Lancet. 2023;402:e9. PubMed
KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al Setbacks in the quest for universal health coverage in Mexico: polarised
politics, policy upheaval, and pandemic disruption.
Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777. PubMedAbstract available
July 2023
HSU NC, Hsu CH COVID-19 and commerce complicate minimum unit pricing effects on health.
Lancet. 2023;402:368. PubMed
WYPER GM, Mackay DF, Fraser C, Lewsey J, et al COVID-19 and commerce complicate minimum unit pricing effects on health -
Authors' reply.
Lancet. 2023;402:368-369. PubMed
O'BRIEN KL, Lemango E The big catch-up in immunisation coverage after the COVID-19 pandemic: progress
and challenges to achieving equitable recovery.
Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468. PubMed
June 2023
WIJAYA R, Johnson M, Campbell N, Stuart B, et al Predicting COVID-19 infection risk in people who are immunocompromised by
antibody testing.
Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180. PubMed
The unfinished agenda of communicable diseases among children and adolescents
before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global
Burden of Disease Study 2019.
Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860. PubMedAbstract available
PELOSI A Disrespectful language about patients with long COVID.
Lancet. 2023;401:2108. PubMed
PRIYA GIRI S, Dubey A Loneliness in the time of COVID-19: an alarming rise.
Lancet. 2023;401:2107-2108. PubMed
BAILEY C, Sanderson T, Townsley H, Goldman J, et al Independent SARS-CoV-2 staff testing protected academic and health-care
institutions in northwest London.
Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917. PubMed
LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al Reimagining health security and preventing future pandemics: the NUS-Lancet
Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
Lancet. 2023;401:2021-2023. PubMed
HUANG C, Huang L, Wang Y, Li X, et al 6-month consequences of COVID-19 in patients discharged from hospital: a cohort
study.
Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810. PubMedAbstract available
PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al Efficacy and safety of luspatercept versus epoetin alfa in
erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk
myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label,
randomised controlled trial.
Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874. PubMedAbstract available
LAL A, Schwalbe N Primary health care: a cornerstone of pandemic prevention, preparedness,
response, and recovery.
Lancet. 2023;401:1847. PubMed
May 2023
JAFFE S US health experts divided on social media age restrictions.
Lancet. 2023;401:1757. PubMed
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and
response.
Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964. PubMed
FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al No time for complacency on COVID-19 in Europe.
Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012. PubMed
ZAROCOSTAS J With the COVID-19 PHEIC over, what next?
Lancet. 2023;401:1642-1643. PubMed
MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
Lancet. 2023;401:1649. PubMed
JAFFE S US Surgeon General: loneliness is a public health crisis.
Lancet. 2023;401:1560. PubMed
EMANUEL EJ, Persad G The shared ethical framework to allocate scarce medical resources: a lesson from
COVID-19.
Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812. PubMedAbstract available
April 2023
AGRAWAL U, Robertson C, Sheikh A Moving towards a precision approach for prevention of severe COVID-19 - Authors'
reply.
Lancet. 2023;401:1424. PubMed
BRANCH-ELLIMAN W, Monach PA Moving towards a precision approach for prevention of severe COVID-19.
Lancet. 2023;401:1423-1424. PubMed
SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al The importance of accountability in tackling future pandemics.
Lancet. 2023;401:1423. PubMed
GALVAO J COVID-19: forgetting a pandemic that is not over.
Lancet. 2023;401:1422-1423. PubMed
THE LANCET Moving past the COVID-19 emergency in the USA.
Lancet. 2023;401:1399. PubMed
ROSS I, Bick S, Ayieko P, Dreibelbis R, et al Effectiveness of handwashing with soap for preventing acute respiratory
infections in low-income and middle-income countries: a systematic review and
meta-analysis.
Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021. PubMedAbstract available
CUENI T Lessons learned from COVID-19 to stop future pandemics.
Lancet. 2023;401:1340. PubMed
HORTON R Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
Lancet. 2023;401:1324. PubMed
LURIE N, Sharfstein JM State-to-state differences in US COVID-19 outcomes: searching for explanations.
Lancet. 2023;401:1314-1315. PubMed
BILLARD MN, Bont LJ The link between respiratory syncytial virus infection during infancy and asthma
during childhood.
Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672. PubMed
ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al Respiratory syncytial virus infection during infancy and asthma during childhood
in the USA (INSPIRE): a population-based, prospective birth cohort study.
Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811. PubMedAbstract available
PETROV AN, Dorough DS, Tiwari S, Welford M, et al Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684. PubMed
HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al Differential diagnosis of blue toes in a newborn baby: might have been maternal
infection with COVID-19?
Lancet. 2023;401:e20. PubMed
GOH AXC, Chae SR, Chiew CJ, Tang N, et al Characteristics of the omicron XBB subvariant wave in Singapore.
Lancet. 2023;401:1261-1262. PubMed
KING B, Zhang X, Harcha WG, Szepietowski JC, et al Efficacy and safety of ritlecitinib in adults and adolescents with alopecia
areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222. PubMedAbstract available
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who
are hypoxic but not requiring ventilatory support (RECOVERY): a randomised,
controlled, open-label, platform trial.
Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510. PubMedAbstract available
PERNER A, Venkatesh B Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587. PubMed
March 2023
SUN L, Jia H, Yang T Chinese medical personnel after the COVID-19 pandemic.
Lancet. 2023;401:1000. PubMed
BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al Assessing COVID-19 pandemic policies and behaviours and their economic and
educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an
observational analysis.
Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461. PubMedAbstract available
QU Z International cooperation to end the COVID-19 pandemic.
Lancet. 2023;401:820. PubMed
THE LANCET Long COVID: 3 years in.
Lancet. 2023;401:795. PubMed
Past SARS-CoV-2 infection protection against re-infection: a systematic review
and meta-analysis.
Lancet. 2023;401:833-842. PubMedAbstract available
COHEN C, Pulliam J COVID-19 infection, reinfection, and the transition to endemicity.
Lancet. 2023;401:798-800. PubMed
STOCKWELL M Effect of a nationwide intervention of electronic letters with behavioural nudges
on influenza vaccination in older adults in Denmark.
Lancet. 2023 Mar 3:S0140-6736(23)00453-1. doi: 10.1016/S0140-6736(23)00453. PubMed
JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al Electronic nudges to increase influenza vaccination uptake in Denmark: a
nationwide, pragmatic, registry-based, randomised implementation trial.
Lancet. 2023 Mar 3:S0140-6736(23)00349-5. doi: 10.1016/S0140-6736(23)00349. PubMedAbstract available
CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al Confronting the evolution and expansion of anti-vaccine activism in the USA in
the COVID-19 era.
Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136. PubMed
February 2023
HUANG S, Gao Z, Wang S China's COVID-19 reopening measures-warriors and weapons.
Lancet. 2023;401:643-644. PubMed
PAN Y, Wang L, Feng Z, Xu H, et al Characterisation of SARS-CoV-2 variants in Beijing during 2022: an
epidemiological and phylogenetic analysis.
Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129. PubMedAbstract available
PREISER W, Maponga T So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific
cooperation going forward.
Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268. PubMed
January 2023
MOHEBBI N, Ritter A, Wiegand A, Graf N, et al Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in
Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3
trial.
Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606. PubMedAbstract available
ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al Global and regional governance of One Health and implications for global health
security.
Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597. PubMedAbstract available
TRAORE T, Shanks S, Haider N, Ahmed K, et al How prepared is the world? Identifying weaknesses in existing assessment
frameworks for global health security through a One Health approach.
Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589. PubMedAbstract available
MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al A global analysis of One Health Networks and the proliferation of One Health
collaborations.
Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596. PubMedAbstract available
October 2022
LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al After 2 years of the COVID-19 pandemic, translating One Health into action is
urgent.
Lancet. 2022 Oct 21. pii: S0140-6736(22)01840. PubMed